RESUMO
Hypercoagulability disorders are commonly encountered in clinical situations in patients with a variety of cancers. However, several hypercoagulability disorders presenting as first symptoms or signs in cancer patients have rarely been reported. We herein described a case of a woman with adenocarcinoma of the lung presenting with deep vein thrombosis, nonbacterial thrombotic endocarditis, recurrent cerebral embolic infarction, and heart failure.
Assuntos
Feminino , Humanos , Adenocarcinoma , Carcinoma Pulmonar de Células não Pequenas , Endocardite , Endocardite não Infecciosa , Insuficiência Cardíaca , Infarto , Pulmão , Neoplasias Pulmonares , Trombofilia , Trombose VenosaRESUMO
Hypercoagulability disorders are commonly encountered in clinical situations in patients with a variety of cancers. However, several hypercoagulability disorders presenting as first symptoms or signs in cancer patients have rarely been reported. We herein described a case of a woman with adenocarcinoma of the lung presenting with deep vein thrombosis, nonbacterial thrombotic endocarditis, recurrent cerebral embolic infarction, and heart failure.
Assuntos
Feminino , Humanos , Adenocarcinoma , Carcinoma Pulmonar de Células não Pequenas , Endocardite , Endocardite não Infecciosa , Insuficiência Cardíaca , Infarto , Pulmão , Neoplasias Pulmonares , Trombofilia , Trombose VenosaRESUMO
Epithelial growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for non-small-cell lung cancer patients. Its untoward cutaneous effects are largely well known and developed in many patients treated with EGFR TKIs. However trichomegaly of eyelash is rarely reported. Although trichomegaly is not a drug-limiting side effect, it could be troublesome of continuing the treatment because of cosmetic issue or eyeball irritation by long eyelashes. Therefore clinicians are needed to pay attention to this uncommon effect. We herein describe erlotinib induced trichomegaly of eyelashes in a woman with adenocarcinoma of the lung.